BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 27
• 30
• 31

• Business

  Vapourtec Release: Green Chemistry Hits Full Flow With China UK Partnership

  December 16, 2013

   · 

  2 min read
• Drug Development

  Biomay AG Successfully Completes Interim Analysis Of Phase 2 Study With The Innovative 3rd Generation Grass Pollen Allergy Vaccine BM32

  December 16, 2013

   · 

  2 min read
• Austrian Science Fund FWF Release: Children’s Understanding Of Alternative Courses Of Events

  December 16, 2013

   · 

  4 min read
• Genetown

  Biousian BioSystems Receives U.S. Patent For Best-In-Class Analgesic

  December 16, 2013

   · 

  3 min read
• Biotech Beach

  MRI Interventions, Inc.’ Clearpoint Neuro Intervention System Recently Profiled By Boston’s ABC-TV Affiliate

  December 16, 2013

   · 

  1 min read
• Biotech Bay

  Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc.'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C

  December 16, 2013

   · 

  1 min read
• FDA

  CSL Behring’s Kcentra® Receives FDA Approval For Use In Warfarin Reversal In Patients Undergoing Surgery

  December 16, 2013

   · 

  8 min read
• Drug Development

  Alnylam Pharmaceuticals Initiates Phase 2 Clinical Trial With ALN-Ttrsc, A Subcutaneously Delivered Rnai Therapeutic Targeting Transthyretin (TTR) In Development For The Treatment Of TTR-Mediated Amyloidosis (ATTR)

  December 16, 2013

   · 

  1 min read
• Drug Development

  Opexa Therapeutics Provides MS Trial Enrollment Update; 70% Of Patients Enrolled

  December 16, 2013

   · 

  1 min read
• Biotech Bay

  Kindred Bio Announces Exercise Of Over-Allotment Option

  December 16, 2013

   · 

  2 min read